Drug intelligence / Profile preview

lysine hydrochloride + inositol + vitamin b12

Development stage
Unknown
Lead developer
Star Silver Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

赖氨肌醇维生素B12口服溶液 (Lysine Inositol Vitamin B12 Oral Solution) is a compound oral solution containing lysine hydrochloride, inositol, and vitamin B12 (cyanocobalamin). It is primarily developed and manufactured by Zhejiang Deyer Pharmaceutical and other manufacturers in China. Lysine is an essential amino acid that promotes growth, development, and nitrogen balance; inositol supports hepatic fat metabolism; and vitamin B12 acts as a key coenzyme for DNA synthesis and red blood cell formation. Together, these components act synergistically to treat loss of appetite and poor growth and development caused by lysine deficiency, particularly in infants and children. It is also being investigated for its potential to promote height growth in children with idiopathic short stature when combined with exercise.

Brand names
AnbeiteDi'er HuicongDiminshiHantangXiaokuihua安贝特迪儿慧聪迪敏士汉唐小葵花
Other names
Lysine Inositol Vitamin B12 Oral Solution小儿赖氨肌醇维生素B12口服溶液赖氨肌醇维B12口服溶液赖氨肌醇维生素B12口服溶液
02

Targets

MMUT (Methylmalonyl-coenzyme A mutase)MTR (Methionine synthase)

Beyond the preview

Go deeper on lysine hydrochloride + inositol + vitamin b12.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lysine hydrochloride + inositol + vitamin b12.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call